GUW-11935-60983
2 vaccinations
5 coded responses
9 check-ins
3 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 05-11
- ZIP prefix
- 460 / IN
- Registered
- 2022-10-16
- Relationship
- Child or adolescent in my care
- Guardian
- 92V-32310-15178
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-08-01
Dose 1 — Pfizer-BioNTech
-
2022-10-13
Dose 2 — Pfizer-BioNTech
-
2022-10-16
Registered in v-safe
-
2022-10-16
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Fair · Site: Pain, Itching · Muscle or body aches, Fatigue or tiredness, Abdominal painAdult check-in
- 2022-10-18
-
2022-10-20
Survey response — day 7, dose 2, dependentMedDRA: Injection site discolouration — Feeling: GoodFree text: Arm is discolored where bandaid covered injection siteMedDRA releases: 2024-11 · check-in free text available
-
2022-11-03
Survey response — day 21, dose 2, dependentMedDRA: Cough, Respiratory tract congestion, Rhinorrhoea — Feeling: FairFree text: Cough (especially in the morning) & runny nose/congestionMedDRA releases: 2024-11 · check-in free text available
- 2022-11-12
- 2022-11-17
-
2022-11-24
Survey response — day 42, dose 2, dependentMedDRA: Cough, Influenza, Pyrexia, Respiratory syncytial virus infection, Respiratory tract congestion — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Currently have the flu and RSV- fever, cough, congestionMedDRA releases: 2024-11 · check-in free text available
-
2022-11-24
Report sent to call center — day 42, dose 2, dependentBe unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-11-25
-
2023-01-12
Survey response — 3 months, dose 2, dependentMedDRA: Eczema, Pruritus — Feeling: FairMedDRA releases: 2024-11
-
2023-04-13
Survey response — 6 months, dose 2, dependentMedDRA: Eczema — Feeling: FairMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-08-01 | Pfizer-BioNTech | No |
| 2 | 2022-10-13 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 12 — day 7, dose 2, dependent
Systemic reaction (other): Arm is discolored where bandaid covered injection site
Release 12 — day 21, dose 2, dependent
Symptoms: Cough (especially in the morning) & runny nose/congestion
Release 12 — day 42, dose 2, dependent
Symptoms: Currently have the flu and RSV- fever, cough, congestion
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Eczema | · | · | ✓ |
| SD | Influenza | · | · | ✓ |
| SD | Pruritus | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory syncytial virus infection | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SRO | Injection site discolouration | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release